Skip to main content
. Author manuscript; available in PMC: 2021 Mar 6.
Published in final edited form as: Leukemia. 2020 Jun 18;35(3):850–862. doi: 10.1038/s41375-020-0922-x

Figure 1: Pattern of whole blood chimerism in engrafting patients in the first year after dCBT combined with haplo-identical CD34+ cells (n = 75).

Figure 1:

The contribution of the haplo-identical donor (Red), the dominant (engrafting) CB unit (Blue) and the non-dominant (non-engrafting) unit (Green) to whole blood chimerism at each time point post-transplant is shown. While the haplo-identical donors contributed to initial hematopoiesis, one CB unit predominated by day 28 in the majority of patients with the median donor chimerism being 100% the dominant CB unit by day 100 and beyond.